ONEVIEW HEALTHCARE PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.33 AUD | +6.45% |
|
+22.22% | +37.50% |
| 04-23 | Oneview Healthcare Posts 9% Rise in Net Operating Cashflow in March Quarter | MT |
| 04-02 | Oneview Healthcare Inks Master Services Agreement with Inova Health for 1,900 Beds | MT |
Valuation
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Capitalization 1 | 37.27 | 98.8 | 128.1 | - | - |
| Enterprise Value (EV) 1 | 37.27 | 87.25 | 122.5 | 126.9 | 125.4 |
| P/E ratio | -3.5 x | -7.4 x | -17.3 x | -46.2 x | 75.7 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | - | 10.5 x | 5.67 x | 4.97 x | 3.86 x |
| EV / Revenue | - | 9.28 x | 5.43 x | 4.92 x | 3.78 x |
| EV / EBITDA | - | -11.1 x | -23.8 x | -63.5 x | 54.1 x |
| EV / FCF | - | -11.8 x | -20.8 x | -28.8 x | 83.6 x |
| FCF Yield | - | -8.46% | -4.82% | -3.47% | 1.2% |
| Price to Book | - | - | - | - | - |
| Nbr of stocks (in thousands) | 532,405 | 667,323 | 673,782 | - | - |
| Reference price 2 | 0.0700 | 0.1481 | 0.1901 | 0.1901 | 0.1901 |
| Announcement Date | 23-02-23 | 24-02-27 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net sales 1 | - | 9.397 | 22.57 | 25.77 | 33.2 |
| EBITDA 1 | - | -7.887 | -5.154 | -1.996 | 2.316 |
| EBIT 1 | - | -8.373 | -5.7 | -2.1 | 1.8 |
| Operating Margin | - | -89.1% | -25.26% | -8.15% | 5.42% |
| Earnings before Tax (EBT) | - | - | - | - | - |
| Net income 1 | -10.87 | -8.935 | -5.776 | -2.568 | 1.666 |
| Net margin | - | -95.08% | -25.59% | -9.96% | 5.02% |
| EPS 2 | -0.0200 | -0.0200 | -0.0110 | -0.004110 | 0.002510 |
| Free Cash Flow 1 | - | -7.382 | -5.9 | -4.4 | 1.5 |
| FCF margin | - | -78.56% | -26.14% | -17.07% | 4.52% |
| FCF Conversion (EBITDA) | - | - | - | - | 64.75% |
| FCF Conversion (Net income) | - | - | - | - | 90.06% |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 23-02-23 | 24-02-27 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2020 S1 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 | 2025 S1 | 2025 S2 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 3.014 | 4.356 | 5.041 | 8.8 | 6.1 | 8.6 | 8.3 |
| EBITDA 1 | - | - | -3.915 | -2.2 | -3.1 | -0.8 | -0.8 |
| EBIT 1 | - | - | -4.049 | -2.5 | -3.3 | -1.1 | -1.1 |
| Operating Margin | - | - | -80.33% | -28.41% | -54.1% | -12.79% | -13.25% |
| Earnings before Tax (EBT) | - | - | - | - | - | - | - |
| Net income 1 | - | -4.462 | -4.473 | -2.8 | -3.5 | -1.3 | -1.3 |
| Net margin | - | -102.42% | -88.73% | -31.82% | -57.38% | -15.12% | -15.66% |
| EPS 2 | -0.0300 | - | -0.0100 | -0.005000 | -0.006000 | -0.002000 | -0.002000 |
| Dividend per Share | - | - | - | - | - | - | - |
| Announcement Date | 20-08-31 | 23-08-28 | 24-02-27 | - | - | - | - |
1EUR in Million2EUR
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - |
| Net Cash position 1 | - | 11.5 | 5.6 | 1.2 | 2.7 |
| Leverage (Debt/EBITDA) | - | - | - | - | - |
| Free Cash Flow 1 | - | -7.38 | -5.9 | -4.4 | 1.5 |
| ROE (net income / shareholders' equity) | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - |
| Assets 1 | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - |
| Capex 1 | - | 0.12 | 0.2 | 0.2 | 0.2 |
| Capex / Sales | - | 1.26% | 0.89% | 0.78% | 0.6% |
| Announcement Date | 23-02-23 | 24-02-27 | - | - | - |
1EUR in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
SELL
Number of Analysts
1
Last Close Price
0.1901
EUR
Average target price
0.283
EUR
Spread / Average Target
+48.91%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +37.50% | 138M | |
| +10.66% | 321B | |
| +26.23% | 220B | |
| +3.30% | 150B | |
| +13.73% | 57.95B | |
| +14.14% | 32.83B | |
| +3.00% | 30.47B | |
| +29.23% | 21.13B | |
| +86.90% | 20.94B | |
| +2.17% | 14.97B |
- Stock Market
- Equities
- ONE Stock
- Financials Oneview Healthcare PLC
